miRNA-503 Promotes Tumor Progression and Is Associated with Early Recurrence and Poor Prognosis in Human Colorectal Cancer.

Abstract:

OBJECTIVES:MicroRNA (miR)-503 is downregulated in several cancers and plays a tumor-suppressive role in carcinogenesis. However, the miR-503 expression pattern, its clinical significance and its molecular mechanism in colorectal cancer (CRC) have not been investigated. METHODS:We analyzed miR-503 expression in normal mucosa (n = 20), adenoma (n = 27) and CRC (n = 20). We quantified miR-503 expression in an independent cohort (n = 191) and investigated the clinical significance of miR-503 in CRC. CRC cell lines were transfected with anti-miR-503 to assess its function and target gene. RESULTS:miR-503 expression increased according to the adenoma-carcinoma sequence. High miR-503 expression was significantly associated with large tumor size, serosal invasion, lymphatic and venous invasion as well as lymph node metastasis. CRC patients with high miR-503 expression had significantly earlier relapse and poorer prognosis than those with low expression. miR-503 was an independent recurrence marker in stage I/II CRC. In vitro, attenuated miR-503 expression resulted in inhibition of proliferation, invasion and migration and acquisition of anoikis of CRC cells. The putative target gene (calcium-sensing receptor) was significantly upregulated after miR-503 attenuation. CONCLUSIONS:miR-503 acts as an 'onco-miR' in CRC. High miR-503 expression is associated with early recurrence and poor prognosis in CRC.

journal_name

Oncology

journal_title

Oncology

authors

Noguchi T,Toiyama Y,Kitajima T,Imaoka H,Hiro J,Saigusa S,Tanaka K,Inoue Y,Mohri Y,Toden S,Kusunoki M

doi

10.1159/000444493

subject

Has Abstract

pub_date

2016-01-01 00:00:00

pages

221-31

issue

4

eissn

0030-2414

issn

1423-0232

pii

000444493

journal_volume

90

pub_type

杂志文章

相关文献

ONCOLOGY文献大全
  • Expression of estrogen receptor beta and phosphorylation of estrogen receptor alpha serine 167 correlate with progression-free survival in patients with metastatic breast cancer treated with aromatase inhibitors.

    abstract::Aromatase inhibitor (AI) is widely used as an endocrine treatment in postmenopausal patients with hormone receptor-positive breast cancer. To identify useful prognostic factors for patients with metastatic breast cancer treated with AI therapy, we investigated the association between several hormone receptor-related f...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000319540

    authors: Motomura K,Ishitobi M,Komoike Y,Koyama H,Nagase H,Inaji H,Noguchi S

    更新日期:2010-01-01 00:00:00

  • Side effects of ifosfamide.

    abstract::Ifosfamide is relatively well tolerated but it can be associated occasionally with life-threatening complications such as arrhythmias and heart failure, severe encephalopathy and hemorrhagic cystitis. Mesna administration can control the urothelial toxicity of ifosfamide, but it is without effect on the other complica...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000073351

    authors: Klastersky J

    更新日期:2003-01-01 00:00:00

  • Value of serum neuron-specific enolase in nonsmall cell lung cancer.

    abstract::To assess the prognostic value of pretreatment serum neuron-specific enolase (NSE) in nonsmall cell lung cancer (NSCLC), levels were measured in 84 NSCLC patients, 40 healthy controls, and 20 patients with benign pulmonary diseases. NSE concentration was higher in NSCLC (11.7 +/- 10.8 ng/ml) (mean +/- SD; median = 9.7...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227163

    authors: Diez M,Torres A,Ortega L,Maestro M,Hernando F,Gomez A,Picardo A,Granell J,Balibrea JL

    更新日期:1993-03-01 00:00:00

  • Effect of single carcinogenic dose of dimethylnitrosamine on antibody responses in the rat.

    abstract::The immunodepressive effect of a single, carcinogenic dose of dimethylnitrosamine was tested in a potent model of renal cancer induction using two antigens which differ in their cellular processing. Responsiveness to sheep red blood cells (SRBC), an antigen requiring the collaboration of both thymus-dependent (T) and ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225521

    authors: Hard GC

    更新日期:1981-01-01 00:00:00

  • Tumor-Infiltrating Lymphocytes in Biopsy Specimens Obtained 7 Days after Starting Chemoradiotherapy for Rectal Cancer Are Predictors of the Response to Chemoradiotherapy.

    abstract:BACKGROUND:Neoadjuvant chemoradiotherapy (nCRT) followed by total mesorectal excision surgery is a standard treatment for locally advanced rectal cancer (LARC). Tumor-infiltrating lymphocytes (TILs) have been reported to be associated with tumor response; however, this remains to be established. We previously reported ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000508922

    authors: Miyakita H,Sadahiro S,Suzuki T,Chan LF,Ogimi T,Okada K,Yamamoto S,Kajiwara H

    更新日期:2020-01-01 00:00:00

  • Activity of formestane in de novo tamoxifen-resistant patients with metastatic breast cancer.

    abstract::In order to assess the feasibility of a sequential hormonal treatment after tamoxifen failure, 24 postmenopausal advanced breast cancer patients (median age 60 years; ECOG PS < or = 1) were treated with formestane (4-hydroxyandrostenedione) 250 mg i.m. fortnightly; 19 patients were estrogen receptor-positive. The site...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000227510

    authors: Noberasco C,Bajetta E,Zilembo N,Di Leo A,Cappuzzo F,Bartoli C,Bono A,Bichisao E

    更新日期:1995-11-01 00:00:00

  • Reintroduction of oxaliplatin: a viable approach to the long-term management of metastatic colorectal cancer.

    abstract::Oxaliplatin-based chemotherapy is an effective first-line treatment option for patients with metastatic colorectal cancer (mCRC), which, in combination with targeted therapies and a sequential treatment approach using all active agents, has extended median overall survival to 2 years and beyond. Prolonged survival bri...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000323491

    authors: Grothey A

    更新日期:2010-01-01 00:00:00

  • Polycythemia Vera Management and Challenges in the Community Health Setting.

    abstract::Patients with polycythemia vera (PV) experience shortened survival, increased risk of thromboembolic and hemorrhagic events, and burdensome symptoms. For all patients with PV, treatment with aspirin and hematocrit control with phlebotomy are recommended. In addition, patients with high-risk status or poor hematocrit c...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000454953

    authors: Gerds AT,Dao KH

    更新日期:2017-01-01 00:00:00

  • High-Risk Human Papillomavirus in Oral Cancer: Clinical Implications.

    abstract::Oral cancer is the eleventh most common cancer globally, with well-established major risk factors of tobacco, areca nut, alcohol, and high-risk human papillomavirus (HR-HPV) types 16 and 18. HR-HPV16/18 are the etiologic agents of cervical cancers and a proportion of oropharyngeal cancers. HPV-associated oropharyngeal...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000485322

    authors: Yete S,D'Souza W,Saranath D

    更新日期:2018-01-01 00:00:00

  • Detection of early ototoxic effect in testicular-cancer patients treated with cisplatin by transiently evoked otoacoustic emission: a pilot study.

    abstract:UNLABELLED:The outlook for patients with testicular germ cell cancer was dramatically improved by the introduction of cisplatin. Well-known side effects of cisplatin (nausea, vomiting, nephrotoxicity, myelosuppression) can be managed with preventive methods. The long life expectancy after this therapy draws attention t...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227724

    authors: Biró K,Baki M,Büki B,Noszek L,Jókúti L

    更新日期:1997-09-01 00:00:00

  • Phase II trial of alternating mFOLFOX6 and FOLFIRI regimens in the first-line treatment for unresectable or metastatic colorectal cancer (KSCC0701).

    abstract:OBJECTIVE:This phase II study examined the efficacy and safety of alternating regimens of mFOLFOX6 and FOLFIRI as a first-line treatment for unresectable or metastatic colorectal cancer. PATIENTS AND METHODS:Forty-eight patients were enrolled in this study. Patients received an alternating regimen of 4 cycles of mFOLF...

    journal_title:Oncology

    pub_type: 杂志文章,多中心研究

    doi:10.1159/000346690

    authors: Oki E,Emi Y,Akagi Y,Tokunaga S,Sadanaga N,Tanaka T,Ogata Y,Saeki H,Kakeji Y,Baba H,Nishimaki T,Natsugoe S,Shirouzu K,Maehara Y,Kyushu Study Group of Clinical Cancer.

    更新日期:2013-01-01 00:00:00

  • Clonal composition of malignant fibrous histiocytoma: analysis by PCR-based assay of the human androgen receptor gene (HUMARA).

    abstract::Malignant fibrous histiocytoma (MFH), the most common soft-tissue sarcoma, consists mainly of two different cell populations: histiocytelike and fibroblastlike cells. It has been suggested to contain a large amount of reactive histiocytes and fibroblasts hard to distinguish from the tumor cells. In this study, the clo...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000011919

    authors: Fujita MQ,Hashida N,Shin M,Nakanishi H,Yoshihara W,Aozasa K

    更新日期:1998-11-01 00:00:00

  • Proliferative activity of Hürthle cell thyroid tumours.

    abstract::To improve our understanding of the basic biological mechanisms of Hürthle cell tumours (HCT), proliferative activity in 20 HCT was determined by Ag-NOR (nucleolar organiser regions) counting and by immunohistochemical markers proliferating cell nuclear antigen (PCNA) and MIB-1. Ten surgically removed Hürthle cell ade...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000011995

    authors: Cör A

    更新日期:1999-07-01 00:00:00

  • A case-control study of breast cancer and psychotropic drug use.

    abstract::The relative risk of breast cancer incidence and tumor promotion associated with psychotropic drug consumption was evaluated in 151 patients with newly diagnosed neoplasms and 151 hospital controls. No significantly altered risk of breast cancer was found in association with the use of diazepam, chlordiazepoxide, anti...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225651

    authors: Wallace RB,Sherman BM,Bean JA

    更新日期:1982-01-01 00:00:00

  • Effect of Neoadjuvant Nab-Paclitaxel plus Gemcitabine Therapy on Overall Survival in Patients with Borderline Resectable Pancreatic Cancer: A Prospective Multicenter Phase II Trial (NAC-GA Trial).

    abstract::We conducted a prospective multicenter phase II trial of patients with borderline resectable pancreatic carcinoma to investigate the efficacy of neoadjuvant nab-paclitaxel plus gemcitabine therapy on overall survival (OS). The clinical trial primarily evaluated OS time from the first day of protocol therapy as a prima...

    journal_title:Oncology

    pub_type: 杂志文章,多中心研究

    doi:10.1159/000478660

    authors: Okada KI,Shimokawa T,Hirono S,Kawai M,Sho M,Satoi S,Matsumoto I,Eguchi H,Murakami Y,Yamada S,Doi M,Yamaue H,NAC-GA investigators.

    更新日期:2017-01-01 00:00:00

  • Final results of a prospective trial of a PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) regimen followed by radiotherapy after curative surgery for pancreatic adenocarcinoma.

    abstract:BACKGROUND:Postoperative management of patients with pancreatic adenocarcinoma (PA) is controversial. METHODS:The aim of this pilot study was to assess the feasibility of postoperative combination chemotherapy followed by radiotherapy in patients aged 18-70 years with a histological diagnosis of PA, and Karnofsky perf...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000086780

    authors: Reni M,Passoni P,Bonetto E,Balzano G,Panucci MG,Zerbi A,Ronzoni M,Staudacher C,Villa E,Di Carlo V

    更新日期:2005-01-01 00:00:00

  • 17-beta-hydroxysteroid dehydrogenase in human breast and endometrial carcinoma. A new development in intracrinology.

    abstract::Intratumoral metabolism and synthesis of estrogens are considered to play very important roles in the pathogenesis and development of various sex steroid-dependent neoplasms including breast and endometrial carcinoma. 17 beta-Hydroxysteroid dehydrogenase (17 beta-HSD) isozymes catalyze the interconversion of estradiol...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000055281

    authors: Sasano H,Suzuki T,Takeyama J,Utsunomiya H,Ito K,Ariga N,Moriya T

    更新日期:2000-01-01 00:00:00

  • Histologic grade and cellular proliferation at the deepest invasive portion correlate with the high malignancy of submucosal invasive gastric carcinoma.

    abstract::To establish appropriate indications for endoscopic treatment of submucosal invasive gastric carcinoma, we investigated clinicopathologic features and proliferating cell nuclear antigen (PCNA) expression at the deepest invasive portion of 192 differentiated submucosal invasive gastric carcinomas that had been surgical...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227486

    authors: Nishida T,Tanaka S,Haruma K,Yoshihara M,Sumii K,Kajiyama G

    更新日期:1995-07-01 00:00:00

  • Establishment and characterization of a human ovarian serous cystadenocarcinoma cell line that produces the tumor markers CA-125 and tissue polypeptide antigen.

    abstract::A cultured cell line (SHIN-3) derived from a human ovarian serous cystadenocarcinoma which consistently produces two tumor markers, CA-125 and tissue polypeptide antigen (TPA) was established. After 1 week of culture of 1 x 10(5) cells, high levels of tumor marker were observed (the total CA-125 release was 1,500 U an...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226813

    authors: Imai S,Kiyozuka Y,Maeda H,Noda T,Hosick HL

    更新日期:1990-01-01 00:00:00

  • Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective comparison with previously known prognostic models.

    abstract:BACKGROUND:Sorafenib, a multitargeted tyrosine kinase inhibitor, is now the treatment of choice for systemic therapy of patients with advanced hepatocellular carcinoma (HCC). Herein, we present the clinical characteristics and outcomes of patients with advanced HCC who were treated with sorafenib. METHODS:Data of 201 ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000327591

    authors: Baek KK,Kim JH,Uhm JE,Park SH,Lee J,Park JO,Park YS,Kang WK,Lim HY

    更新日期:2011-01-01 00:00:00

  • Serrated adenoma of the colorectum undergoes a proliferation versus differentiation process: new conceptual interpretation of morphogenesis.

    abstract:OBJECTIVE:Serrated adenoma (SA) consists of glands both with intraluminal projection of tall columnar cells, which resemble the terminally differentiated cells in the surface epithelium, and with concave short cells, which resemble progenitor crypt cells of the colon. The aim of this study was to clarify the relationsh...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000151359

    authors: Jiao YF,Nakamura S,Sugai T,Yamada N,Habano W

    更新日期:2008-01-01 00:00:00

  • Long-Term Survival and Cure in Distant Metastatic Breast Cancer.

    abstract:BACKGROUND:Previous data showed that distant metastatic breast cancer (MBC) might be curable in up to 3% of the cases in selected patients, mostly young, with good performance status and with low-volume metastatic disease, mainly by an aggressive multidisciplinary approach including aggressive combination chemotherapy ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000500298

    authors: Güth U,Elfgen C,Montagna G,Schmid SM

    更新日期:2019-01-01 00:00:00

  • Methyl-CCNU in malignant melanoma--a divided dose schedule of administration.

    abstract::Methyl-CCNU (NSC-95441) was administered to patients with malignant melanoma in a split dose schedule. Nausea and vomiting were eliminated as clinical problems during therapy. Response rate to the drug seemed somewhat lower than the average of three previously reported disease-oriented phase II trials, though the diff...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225178

    authors: Wittes RE,Hong WK,Gatchell L,Krakoff IH,Golbey RB

    更新日期:1977-01-01 00:00:00

  • Localisation of Hodgkin's disease and lymphomas by 67-gallium substraction scanning.

    abstract::67Ga-subtraction scan was found to be useful and a promising new method for the pre-treatment evaluation of the patient with Hodgkin's disease or non-Hodgkin's lymphoma. The scan appeared to be most accurate in the neck, chest, and axillary regions. It appears to offer a means of increasing the accuracy of evaluating ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225217

    authors: Krolikiewicz H,Maruyama Y,Deland FH,Beihn RM,Hafner T,Utley JF

    更新日期:1977-01-01 00:00:00

  • Effects of PSK on resistance to bacterial infection in splenectomized mice.

    abstract::Nontumor-bearing C3H/He mice were splenectomized and intravenously inoculated 7 days later with Streptococcus pneumoniae, Pseudomonas aeruginosa, or Escherichia coli. The survival rate was reduced by splenectomy in the animals inoculated with S. pneumoniae, but did not change in those inoculated with P. aeruginosa or ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226566

    authors: Ando T,Motokawa I,Sakurai K,Ohmura Y,Matsunaga K,Fujii T,Yoshikumi C,Taguchi T

    更新日期:1988-01-01 00:00:00

  • Prognostic Factors in HER2-Positive Primary Breast Cancer Patients Treated Using Neoadjuvant Chemotherapy Plus Trastuzumab.

    abstract:BACKGROUND:It is unclear for whom new anti-human epidermal growth factor receptor 2 (anti-HER2) agents, such as pertuzumab and T-DM1, should be considered. We investigated prognostic factors before neoadjuvant chemotherapy (NAC) among HER2-positive invasive breast cancer patients and those after NAC among patients who ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000502910

    authors: Fujita N,Enomoto Y,Inakami K,Yanagisawa T,Iguchi C,Aono T,Nomura T,Yamamoto H,Kasugai T,Shiba E

    更新日期:2020-01-01 00:00:00

  • Single-agent gemcitabine for biliary tract cancers. Study outcomes and systematic review of the literature.

    abstract:OBJECTIVE:The aim of this study was to investigate the outcomes of gemcitabine-treated patients with inoperable biliary tract cancers. METHODS:We conducted a retrospective study of consecutively treated 22 inoperable biliary tract cancer patients with gemcitabine (500-1,000 mg/m(2) on days 1, 8, 15 every 4 weeks) as f...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000098109

    authors: Kiba T,Nishimura T,Matsumoto S,Hatano E,Mori A,Yasumi S,Doi R,Ikai I,Kitano T,Nishimura T,Yoshikawa K,Ishiguro H,Yanagihara K,Doi E,Teramukai S,Fukushima M

    更新日期:2006-01-01 00:00:00

  • Stem cell relationships and the origin of gastrointestinal cancer.

    abstract::Gastrointestinal stem cells have the capacity for long-term self-replication and the ability to give rise to all other epithelial cell lineages. These properties make them essential since they maintain tissue homeostasis by regulating cell turnover depending on the current demand. However, they are also important play...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000086625

    authors: Schier S,Wright NA

    更新日期:2005-01-01 00:00:00

  • Deoxycytidylate aminohydrolase activity in the Novikoff hepatoma is dependent on the localization of the tumor.

    abstract::The activity of deoxycytidylate aminohydrolase, a pivotal enzyme for pyrimidine biosynthesis in mammalian tissue, is 100x greater in the Novikoff hepatoma harvested from the intraperitoneal cavity than in the same tumor excised from either subcutaneous or intramuscular sites. The increased enzyme activity in the intra...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226832

    authors: Sheid B

    更新日期:1990-01-01 00:00:00

  • Is capecitabine efficacious in triple negative metastatic breast cancer?

    abstract:BACKGROUND:Recent data suggest that capecitabine may have little efficacy in women with metastatic triple negative breast cancer (TNT). We have therefore retrospectively analysed capecitabine outcome in the TN subgroup of patients with locally advanced or metastatic breast cancer treated in our unit. PATIENTS AND METH...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000323175

    authors: Kotsori AA,Dolly S,Sheri A,Parton M,Shaunak N,Ashley S,Walsh G,Johnston S,Smith IE

    更新日期:2010-01-01 00:00:00